Concepedia

Radosław Zagożdżon

RZ

57

Publications

1.7K

Citations

27

H-Index

1996

Active since

Affiliations

Medical University of Warsaw(Current)

Institute of Biochemistry and Biophysics, Polish Academy of Sciences

Beth Israel Deaconess Medical Center

Postgraduate School of Molecular Medicine

Harvard University

Radosław Zagożdżon is an author at Medical University of Warsaw specializing in medicine, tumor biology, and pharmacology.

ORCID

Top concepts

Publications per year

1996–2024

57

Publications

57

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors

Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk‐Jarzynka et al. · Cancer Immunology Research · 2018 · 106 citations · Full text

Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice

Wojciech Feleszko, Radosław Zagożdżon, Jakub Gołąb et al. · European Journal of Cancer · 1998 · 85 citations

, , +7

Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer

Patrick C. O’Leary, Marta Terrile, Małgorzata Bajor et al. · Breast Cancer Research · 2014 · 77 citations · Full text

Serine Biosynthesis Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells

Emilia Białopiotrowicz, Monika Noyszewska‐Kania, Neli Kachamakova‐Trojanowska et al. · Cancers · 2020 · 63 citations · Full text

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents

Małgorzata Bajor, Agata O. Zych, Agnieszka Graczyk‐Jarzynka et al. · British Journal of Cancer · 2018 · 62 citations · Full text

Rows per page

1–5 of 57